TIANJIN, Sep 23, 2009 (SinoCast Daily Business Beat via COMTEX) -- Tianjin Tasly Pharmaceutical Co., Ltd. (SHSE: 600535) will join hands with other four shareholders inject more capital into Tianjin Shanghui (Holdings) Co., Ltd. (transliterated), in an attempt to indirectly subscribe for shares of China Bohai Bank.

Presently, Tianjin Shanghui (Holdings) holds an 8% stake in the national joint-stock commercial bank based in Tianjin Municipality, north China.

After the capital increment, Tianjin Shanghui (Holdings)'s total registered capital will be enlarged to CNY 1.38 billion from CNY 600 million. This time, the Shanghai-listed pharmaceuticals producer will additionally infuse CNY 284.8 million into the target company, taking a 29% stake as before.

China Bohai Bank has been growing fast since the establishment in December 2005. On July 29, 2009, the lender announced that it would additionally issue 3.5 billion shares to its shareholders at CNY 1 apiece, and total capital gained from this move would be used in its capital base supplement.

In order to successfully launch its initial public offering in 2013, China Bohai Bank expects to come to China's capital adequacy ratio (CAR) standard as soon as possible.